Rimonabant and taranabant are two extensively studied cannabinoid-1 receptor (CB1R) inverse agonists. Their effects on in vivo peripheral tissue metabolism are generally well replicated. The central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback